Blog
A New Stablecoin Is Taking Aim at Circle's USDC. Here's What Investors Need to Know.
There's a new stablecoin in town that wants to shake up the industry. On June 30, a consortium of over 140 organizations announced the launch of Open USD, which has an enticing offer for partners
Ladder Capital's Asset Management Head Sells 35,000 Shares — What's Really at Stake?
On May 29 and June 2, 2026, Robert Perelman, Head of Asset Management at Ladder Capital Corp (NYSE:LADR), reported the open-market sale of 35,000 shares of Common Stock, according to a SEC Form 4
3 Stocks to Buy on the AI Infrastructure Sell-Off
While the market has been driven higher by artificial intelligence (AI) stocks over the past few years, these stocks have recently pulled back, creating a potential buying opportunity. The fear is
Vanguard VCIT vs iShares MUB: Which Bond ETF Should You Choose?
Investors seeking tax-exempt income may prefer iShares National Muni Bond ETF (NYSEMKT:MUB), while those prioritizing higher yields and lower costs could favor Vanguard Intermediate-Term Corporate
Prediction: SPHQ Will Be the Smartest Buy of 2026. Here's Why.
Despite some bouts of volatility and ongoing concerns about the Iran war, rising inflation, and volatile oil prices, the S&P 500 is on pace for another strong year. The index is nearly up 9% year to
Vanguard VT vs State Street SPDW Global ETF Showdown. Which World-Spanning Fund Is the Better Buy?
Investors choosing between Vanguard Total World Stock ETF (NYSEMKT:VT) and State Street SPDR Portfolio Developed World ex-US ETF (NYSEMKT:SPDW) must decide whether to include U.S. equities in a
Berkshire Hathaway's Giant Cash Pile Earns More When Rates Stay High. Here's Why That Matters.
Berkshire Hathaway (NYSE: BRKA)(NYSE: BRKB) is widely followed for its investment approach, which includes buying companies outright and buying shares of publicly traded companies. However, holding
Could This Dividend Stock Help Make You Rich Through Compounding?
Albert Einstein called compound interest the eighth wonder of the world, quipping, "He who understands it, earns it... he who doesn't... pays it." Investing in dividend-paying stocks is one way to
EPR's CFO Sold Shares at a Premium — Here's the Bet Behind the Stock
Mark Alan Peterson, EVP & Chief Financial Officer, reported an open-market sale of 8,334 shares of EPR Properties (NYSE:EPR) for a total consideration of ~$500,000, according to the SEC Form 4
Missed the First Wave of Artificial Intelligence (AI) Stocks? These 2 Aggressive Plays Are Your Second-Chance Buys
The first wave of artificial intelligence (AI) investing produced several major winners, such as Nvidia, Broadcom, and Taiwan Semiconductor Manufacturing. These companies grew into
Bitcoin ETFs Saw Outflows of $2 Billion in 2 Weeks. Should You Sell?
Bitcoin (CRYPTO: BTC) spot exchange-traded funds (ETFs) lost $1.8 billion in the week ending June 26, the second-worst weekly outflow since these products launched in January 2024, then lost another
I'm Calling It: This Is the Best AI Stock to Buy in the Second Half of 2026
A large percentage of AI stocks already trade at a rich premium. So despite these companies' promising long-term revenue growth potential, investors may not profit as much as they predict.
To
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Healthcare is changing through AI and personalized cell therapy. Which of these high-growth innovators represents the better risk-adjusted opportunity for your portfolio today as you evaluate
Sandisk Stock Was the Biggest Winner in the First Half of 2026. What's Next for the Second Half?
Sandisk (NASDAQ: SNDK) is the best-performing S&P 500 stock so far in 2026, and it isn't particularly close. It's up around 800% so far in 2026, easily outperforming second-place Micron Technology
Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?
Choosing between Dyne Therapeutics (NASDAQ:DYN) and Recursion Pharmaceuticals (NASDAQ:RXRX) requires balancing the potential of targeted muscle-tissue therapies against the broad, data-driven power
Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up?
Comparing Vanguard Health Care ETF (NYSEMKT:VHT) and iShares Biotechnology ETF (NASDAQ:IBB) reveals a choice between broad sector diversification and specialized exposure to the high-growth
SOXX vs. CHAT ETF: Semiconductor Chips Beat AI Software
Comparing Roundhill Generative AI & Technology ETF (NYSEMKT:CHAT) and iShares Semiconductor ETF (NASDAQ:SOXX) involves weighing a broad approach to artificial intelligence software and
Oil is Starting to Flow Out of the Strait of Hormuz Again. Should You Still Buy Oil Stocks?
The geopolitical conflict in the Middle East pushed oil prices sharply higher. Now that the tensions have cooled, the price of oil has fallen back to its levels prior to the conflict. Major oil
3 Retirement Expenses You May Not Be Prepared For
Retirement is an exciting milestone. But it's also not something you should jump into.
It's important to plan for retirement so you don't subject yourself to needless financial stress once you stop
Here's the Precise Timeline of When SpaceX Insiders Can Dump Their Shares on Retail Investors
Three weeks ago, Elon Musk's artificial intelligence (AI) and space infrastructure goliath, Space Exploration Technologies (SpaceX) (NASDAQ: SPCX), etched its name in Wall Street's record books.
A Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transaction.
Jonathan Wygant, Vice President and Chief Accounting Officer of Veracyte (NASDAQ:VCYT), reported the exercise of 24,000 options and immediate open-market sale of the same number of shares for a
Visa Is Having a Rare Down Year. Is the Cash Flow Machine Finally a Bargain?
Visa (NYSE: V) has historically been a market-beating stock, but it's been struggling this year, and investors are noticing several headwinds. The stock is down 2% this year, compared with a 9%
Ziff Davis' CFO Sold 18,000 Company Shares. Here's a Closer Look at the Transaction.
Bret Richter, Chief Financial Officer of Ziff Davis (NASDAQ:ZD), reported the sale of 18,000 shares of Common Stock in an open-market transaction on June 10, 2026, according to an SEC Form 4 filing.
The EPR Insider Sale Is Noise — The Signal Is Rising Demand for Experiences
Gwendolyn Mary Johnson, SVP - Asset Management at EPR Properties (NYSE:EPR), reported the sale of 2,000 shares of Common Stock via an indirect open-market transaction on June 23, 2026, according to
General Motors vs. Lucid: Which Automotive Stock Is a Better Buy in 2026?
General Motors (NYSE:GM) and Lucid Group (NASDAQ:LCID) represent two different eras of automotive manufacturing. Investors must decide between a profitable industry giant and a high-growth luxury


